scispace - formally typeset
T

Theresa Köbe

Researcher at McGill University

Publications -  34
Citations -  899

Theresa Köbe is an academic researcher from McGill University. The author has contributed to research in topics: Cognitive decline & Medicine. The author has an hindex of 15, co-authored 24 publications receiving 552 citations. Previous affiliations of Theresa Köbe include German Center for Neurodegenerative Diseases & Douglas Mental Health University Institute.

Papers
More filters
Journal ArticleDOI

Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment

TL;DR: Preliminary evidence is provided that omega-3 FA intake combined with aerobic exercise and cognitive stimulation prevents atrophy in AD-related brain regions in MCI patients, compared to omega- 3 FA intake plus the control condition of stretching and toning.
Journal ArticleDOI

Safety and tolerability of spermidine supplementation in mice and older adults with subjective cognitive decline

TL;DR: The data demonstrate that sperMidine supplementation using a spermidine-rich plant extract is safe and well-tolerated in mice and older adults, and allow for longer-term intervention studies in humans to investigate the impact of sper midine treatment on cognition and brain integrity.
Journal ArticleDOI

The effect of spermidine on memory performance in older adults at risk for dementia: A randomized controlled trial

TL;DR: In this pilot trial, nutritional spermidine was associated with a positive impact on memory performance in older adults with subject cognitive decline, and the beneficial effect might be mediated by stimulation of neuromodulatory actions in the memory system.
Journal ArticleDOI

Impact of Resveratrol on Glucose Control, Hippocampal Structure and Connectivity, and Memory Performance in Patients with Mild Cognitive Impairment

TL;DR: This proof-of-concept study indicates for the first-time that resveratrol intake may reduce glycated hemoglobin A1c, preserves hippocampus volume, and improves hippocampus RSFC in at-risk patients for dementia.